Lung Cancer Considered

Lung Cancer Considered

Por: IASLC
Dr. Stephen Liu and Dr. Narjust Florez host Lung Cancer Considered, the podcast of The International Association for the Study of Lung Cancer (IASLC). IASLC is the only global organization dedicated solely to the study of lung cancer and other thoracic malignancies. Founded in 1974, the association's membership includes more than 11,000 lung cancer specialists across all disciplines in over 100 countries, forming a global network working together to conquer lung and thoracic cancers worldwide. The association also publishes the Journal of Thoracic Oncology, the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis and treatment of all thoracic malignancies. Visit www.iaslc.org for more information.

Lung Cancer considered is funded in part by Current sponsors:
• AbbVie
• AstraZeneca
• Gilead
• J&J
• Summit
366 episodios disponibles

Latest episodes of the podcast Lung Cancer Considered

Mostrando página 2 de 19

LCC in Korean: WCLC 2025 Highlights 30/09/2025
IASLC Lung Cancer Considered: FDA Approval: Subcutaneous Immunotherapy 26/09/2025
LCC in Mandarin: WCLC 2025 Highlights with Experts from Taiwan 18/09/2025
LCC in Portuguese: WCLC 2025 Highlights 16/09/2025
LCC in Spanish: WCLC 2025 Through a Junior Faculty Lens 11/09/2025
LCC in Hebrew: WCLC 2025 Highlights 10/09/2025
Live From WCLC 2025: Tuesday Highlights & Meeting Summary 09/09/2025
LCC in Spanish: WCLC 2025 Highlights 09/09/2025
Live From WCLC 2025: Monday Highlights 08/09/2025
LCC in Mandarin: WCLC 2025 Highlights 08/09/2025
Live From WCLC 2025: Sunday Highlights 07/09/2025
"I'm in Barcelona, Now What?" — Tips for First-Time WCLC Attendees 06/09/2025
LCC in Mandarin: Neoadjuvant and Perioperative Therapy for Locally Advanced NSCLC 29/08/2025
IASLC - ALK Positive Summit 26/08/2025
LCC in Greek: Virtual Tumor Board - ALK NSCLC 22/08/2025
Lung Cancer Considered--STK11 and KEAP1 as resistance mechanisms to immunotherapy 19/08/2025
LCC in Cantonese: Novel Treatment for Advanced EGFR Mutant Lung Cancer 15/08/2025
FDA Approval: Zongertinib for HER2 Mutant NSCLC 12/08/2025
LCC in Arabic: Arab Women's Voices in Thoracic Oncology 08/08/2025
Artificial Intelligence (AI) and Lung Cancer Treatment Decisions 05/08/2025
« Primera ‹ Anterior 1 2 3 4 ... 19 Siguiente › Última »
© 2003-2026 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA